Introduction
The highly malignant Ewing sarcoma is the second most common bone tumor in adolescents and young adults. It belongs to a family of tumors which includes other malignancies such as primitive neuroectodermal tumor, Askin tumor, olfactory neuroblastoma, malignant ectomesenchymoma and extraskeletal Ewing sarcoma (Horowitz et al., 1997) . Over 90% of these tumors have recurrent reciprocal translocations which join the EWS gene on chromosome 22 to an ETS family gene, either FLI-1 on chromosome 11 or ERG on chromosome 21 (Delattre et al., 1992; Zucman et al., 1993; Sorensen et al., 1994) . These translocations generate chimeric proteins in which the amino terminal portion of the EWS protein, a potent transcriptional activator, is linked to the DNA binding domains of either FLI-1 or ERG (May et al., 1993a; Ohno et al., 1993; Bailly et al., 1994) . These fusion proteins transform NIH3T3 cells (May et al., 1993b) , and appear to be essential for maintaining the oncogenic and tumorigenic properties of tumor cells (Ouchida et al., 1995; Kovar et al., 1996; Tanaka et al., 1997) . Ewing sarcoma cells maintain a primitive phenotype but have the potential to dierentiate in vivo or in vitro into a neural phenotype (Lipinski et al., 1987; Noguera et al., 1992; O'Regan et al., 1995) .
Treatments include intensive combination chemotherapy, local ionizing radiation and surgery. Unfortunately, prognosis is poor in the case of large primary tumors or metastatic disease. As apoptosis appears to be the main underlying mechanism whereby chemotherapy and radiation kill tumor cells (Fisher, 1994) , identi®cation of events that can antagonize apoptosis in Ewing tumors is essential for improving their response to conventional therapies.
In non-stimulated cells, transcription factor NF-kB is sequestered in the cytoplasm through binding to one member of a family of inhibitors known as IkBs (Baeuerle and Henkel, 1994; Baldwin, 1996; Baeuerle and Baltimore; 1996; Whiteside et al., 1997) . Upon stimulation of the cells with various inducers, such as TNFa, IL1-b, viruses and double-stranded RNA, two serine residues (Ser32 and Ser36) of the IkB protein are phosphorylated by a multisubunit IkB kinase complex (IKK) (reviewed in Maniatis; 1997; Stancovski and Baltimore, 1997) . This phosphorylation is a signal for ubiquitination and degradation of IkB in the 26S proteasome, and for subsequent translocation of the NF-kB complex to the nucleus (Verma et al., 1995) . Originally described as regulators of immune and in¯ammatory responses (reviewed in Baeuerle and Henkel, 1994) , members of the NF-kB family of transcription factors have recently been found to induce the resistance of several cell types to apoptotic stimuli. For example, compared to wild-type controls, cells from mice lacking the NF-kB/Rel A gene showed increased suceptibility to TNF-a-induced apoptosis (Beg and Baltimore, 1996) . Also, inhibition of NF-kB nuclear translocation enhanced apoptotic killing by agents that activate NF-kB (Van Antwerp et al., 1996; Liu et al., 1996) , but not by apoptotic stimuli that do not activate this factor . Additionally, NF-kB exerts a protective eect against apoptosis induced by transforming growth factor b1 or by human immunode®ciency virus-1 (Arsura et al., 1996; DeLuca et al., 1998) , and is implicated in the antiapoptotic function of insulin (Bertrand et al., 1998) . Furthermore NF-kB plays an important role in maintaining hematopoietic cell survival in response to IL-3 and to the oncogenic TEL/platelet-derived growth factor receptor b fusion protein (BesancË on et al., 1998) . The role of NF-kB in the survival of neural cells seems less clear. For example, on the one hand, induction of NF-kB by TNFa was shown to protect cultured rat brain neurons against metabolic and oxidative insults (Cheng et al., 1994) . On the other hand, however, a protective eect against glutamate-elicited neurotoxicity was obtained after blockage of NF-kB by aspirin or sodium salicylate (Grilli et al., 1996; Grilli and Memo, 1999) .
Our present study focuses on the role of NF-kB in the resistance of Ewing tumor cells to apoptotic stimuli. Thus, we investigated whether NF-kB exerts a protective eect against TNFa-induced apoptosis in these cells. We show that inhibition of NF-kB as a consequence of the stable expression of a super repressor form of IkBa rendered these cells more susceptible to TNFa-induced killing. We also de®ne the cyclin kinase dependent inhibitor p21
Waf1/Cip1 as an antiapoptotic protein induced by TNFa and demonstrate that this induction requires NF-kB activity. These results, therefore, identify a novel mechanism that explains the ability of NF-kB to suppress the apoptotic response.
Results

Generation of Ewing tumor cell lines with arti®cially blocked NF-kB activity
TNFa signaling gives rise to a number of events including activation of NF-kB. In several cell lines, it has been reported that TNFa-induced apoptosis is limited by the coactivation of NF-kB-dependent anti-apoptotic genes. In this study, we investigated the functional consequences of TNFa-induced NF-kB activation on the sensitivity of Ewing tumor cells to apoptosis. For this purpose, we generated stable transformants expressing the IkBa(A32/ 36) mutant, a super repressor form of IkBa. The IkBa(A32/36) contains serine-to-alanine mutations at residues 32 and 36, which confer resistance to signalinduced phosphorylation and subsequent proteasomemediated degradation. The mutant protein still binds to NF-kB and therefore behaves like a constitutive repressor of NF-kB activity.
Transfection of EW7 cells with a vector encoding for IkBa(A32/36) followed by selection with geneticin, generated stable transformants (EW7MAD) from which two clones (EW7MAD1 and EW7MAD2) were isolated. TNFa-induced NF-kB activity in these transformants was compared to that induced in cells transfected with the empty pcDNA vector (EW7pc). Two methods were used for NF-kB activity measurement: Electrophoretic mobility shift assay (EMSA) analysis of nuclear extracts using a 32 P-labeled oligonucleotide containing the NF-kB consensus sequence and measurement of the ability of TNFa to activate an NF-kB-dependent reporter gene.
As shown in Figure 1a , EMSA analysis revealed that TNFa induced a strong NF-kB DNA binding activity in EW7pc cells which appeared as a single band. Supershift experiments revealed that this band represented a p50/p65 heterodimer (not shown). The lower band observed in all samples was non-speci®c since it was not supershifted by anti p50 or anti p65 antibodies. Induction of NF-kB DNA-binding activity by TNFa was almost completely abolished in the IkBa(A32/36)-expressing EW7MAD, EW7MAD1 and EW7MAD2 cells (Figure 1a) .
For measurement of NF-kB transcriptional activity, cells were transiently transfected with the (Igk)3-conaluc plasmid, a luciferase reporter construct containing three kB sites of the Igk chain enhancer upstream of the minimal conalbumin promoter (Munoz et al., 1994) . As shown in Figure 1b , the luciferase activity measured in TNFa-treated EW7pc cells was about 50-fold higher than that measured in non-treated cells. Consistent with the EMSA assays, TNFa did not increase NF-kB transcriptional activity in EW7MAD, EW7MAD1 and EW7MAD2 cells.
In order to con®rm that the degradation resistant IkBa(A32/36) was actually expressed in the stable transformants, we tested its expression by Western blotting (Figure 1c ). Although the anti-IkBa antibody recognizes both the wild-type and the mutated IkBa, the mutated IkBa cDNA we used encodes a protein which migrates slightly slower than the wild-type (Cai et al., 1997) . This allowed us to compare the expression of both forms upon TNFa treatment. In all ®ve cell lines, a 36 kDa band corresponding to the wild-type degradable IkBa was observed which, as expected, strongly decreased upon TNFa treatment. The 38 kDa band corresponding to the mutated IkBa was detected in the cells transfected with the vector encoding the IkBa(A32/36) mutant. Its expression was increasd after treatment of the cells with TNFa. A similar ®nding was also described by Cai et al. (1997) . These results demonstrate that the IkBa(A32/36) was stably expressed in the EW7MAD, EW7MAD1 and EW7MAD2 cells and that TNFa treatment resulted in the disappearance of only the endogenous wild-type IkBa.
Stable expression of a super repressor form of IkBa increases the sensitivity of Ewing tumor cells to TNFa-induced apoptosis
Induction of apoptosis by TNFa was assessed by microscopic observation of morphological changes characteristic of apoptosis (i.e. condensation and fragmentation of the nucleus) ( Figure 2a ). As shown in Figure 2b , EW7pc cells are resistant to TNFainduced apoptosis with only 5% of the cells showing fragmented nuclei after an 18 h treatment with 20 ng/ ml of the cytokine. The same percentage was observed in parental EW7 cells (not shown). On the other hand, in EW7MAD1 and EW7MAD2 cells, TNFa treatment resulted in a pronounced apoptotic eect with over 50% of the nuclei being fragmented. Thus, clearly, the expression of the super-repressor form of IkBa overcomes the block to TNFa-induced apoptosis. In order to con®rm these microscopic observations, we also measured other indicators of apoptosis (Green, 1998) . DEVD-sensitive caspase 3 was found to be activated by TNFa treatment in the EW7MAD1 and EW7MAD2 clones whereas no activation occurred in the EW7pc cells (Figure 2c ). Reduction of mitochondrial membrane potential (DCm), a hallmark of apoptosis, was also measured using DiOC 6 (3), a p21
Waf1/Cip1 mediates the antiapoptotic effect of NF-kB D Javelaud et al cyanine dye that accumulates in the mitochondrial matrix under the in¯uence of the DCm. As shown in Figure 2d , these measurements further con®rmed the apoptosis-sensitive phenotype of EW7MAD1 cells. Similar results were obtained with EW7MAD2 cells (not shown). Stable transformants of another Ewing tumorderived cell line, EW1, were also generated by transfection with the pcDNA control vector or the vector encoding for the super repressor form of IkBa. As in EW7 cells, inhibition of NF-kB activity sensitized EW1 cells to TNFa-induced killing, thus con®rming the protective eect of this transcription factor in Ewing tumor cells (not shown).
Inverse correlation between NF-kB activity and susceptibility to cell death induced by chemotherapeutic agents Previous publications reported induction of NF-kB activity by chemotherapeutic agents in dierent transformed cells Das and White, 1997) . In contrast to these observations we found that NF-kB was marginally induced in EW7 cells. Therefore, in order to investigate whether NF-kB also confers resistance to chemotherapy-induced cell death, EW7 cells which express a very low basal NF-kB activity were pretreated with TNFa before treatment with doxorubicin or daunorubicin, two apoptosisinducing chemotherapeutic agents. As shown in Figure  3 , pretreatment with TNFa resulted in a reduced sensitivity of EW7pc cells to both agents. In contrast, in the EW7MAD1 and EW7MAD2 clones, the percentage of apoptotic cells obtained after treatment with these agents was higher in TNFa-pretreated cells as compared to non-pretreated controls (Figure 3) . These results indicate that NF-kB activity induced by TNFa protects EW7 cells not only against TNFainduced apoptosis but also against doxorubicin-and daunorubicin-induced killing.
Analysis of the expression of antiapoptotic proteins in control and in IkBa(A32/36)-expressing EW7 cells
Our results suggest that NF-kB may enhance the expression of anti-apoptotic proteins in Ewing tumor Waf1/Cip1 mediates the antiapoptotic effect of NF-kB D Javelaud et al cells such as Bcl-2, c-IAP1, c-IAP2 which are regulated by NF-kB in various cell lines (reviewed in JaÈ aÈ ttelaÈ , 1999b). Recently, a role for the p21 Waf1/Cip1 protein in the protection of certain cell types against apoptosis has also been reported (reviewed in Asada et al., 1999; Wang et al., 1999b) . In order to further clarify the antiapoptotic mechanism of NF-kB in Ewing tumor cells, the expression of these anti-apoptotic proteins was analysed after TNFa-treatment of control cells and of IkBa(A32/36)-expressing EW7 cells. Since an antiapoptotic function of the EWS-FLI-1 chimeric protein was reported (Yi et al., 1997) , we also investigated the eect of TNFa-treatment on EWS-FLI-1 expression in these cells. Cells were incubated with TNFa for 8 h or left untreated, and extracts were then prepared. As presented in Figure 4 , in EW7 or expression was clearly enhanced in both EW7 and EW7pc cells (Figure 4 ). This increase in p21
Waf1/Cip1 expression was not observed in the EW7MAD1 and EW7MAD2 clones indicating that NF-kB activity was required for the TNFa-induced expression of p21
Waf1/Cip1
( Figure 4) . The expression of p21 Waf1/Cip1 is controlled at both the transcriptional and the post-transcriptional level, and p53 has been shown to be a major transcriptional regulator of p21
Waf1/Cip1 expression (reviewed in Gartel and Tyner, 1999) . The fact that induction of p21 Waf1/Cip1 expression in control EW7 and EW7pc cells was not accompanied by a modulation of p53 level (Figure 4) suggests that TNFa-induced p21 Waf1/Cip1 expression was p53-independent.
As in EW7 cells, expression of IkBa(A32/36) in EW1 cells abolished the induction of p21 Waf1/Cip1 expression by TNFa (not shown), thus con®rming the requirement of NF-kB activity for this induction.
Inhibition of TNFa-induced apoptosis by overexpression of p21
To demonstrate that p21
Waf1/Cip1 exerts a protective eect against TNFa-induced apoptosis in Ewing tumor cells, we transiently transfected the EW7MAD1 and EW7MAD2 cells with an expression vector encoding the p21
Waf1/Cip1 protein, or with the empty pCEP4 vector. Both were added together with a construct encoding the Green Fluorescent Protein (GFP), allowing for the identi®cation of transfected cells. Subsequently, cells were either left untreated or were treated with TNFa for 18 h. Nuclear fragmentation was evaluated by Hoechst staining and results were quanti®ed by counting the number of apoptotic cells in the population of transfected cells (GFP positive) as described (BesancË on et al., 1998) . A quantitative representation of these data is shown in Figure 5 . Both EW7MAD1 and EW7MAD2 cells transfected with the p21 Waf1/Cip1 encoding vector exhibited a reduced sensitivity to TNFa-induced apoptosis as compared to cells transfected with the empty vector. These results strongly support the conclusion that p21
Waf1/Cip1 is a mediator of the anti-apoptotic eect of TNFa-induced NF-kB in Ewing tumor cells. Waf1/Cip1 by TNFa in EW7 cells is dependent on NF-kB activity. EW7, EW7pc, EW7MAD1 or EW7MAD2 cells were left untreated or were treated for 8 h with TNFa (20 ng/ml). Equal protein cell lysates were analysed by Western blot for the expression of Bcl-2, c-IAP1, c-IAP2, p21
Waf1/ Cip1 p53 and EWS ± FLI-1 proteins. The blots were also probed with an antibody to actin as a control for protein loading equivalence Waf1/Cip1 mediates the antiapoptotic effect of NF-kB D Javelaud et al
Discussion
Apoptosis is a genetically controlled process of cellular suicide that is implicated in the homeostasis of tissues and can be antagonized by a set of survival proteins. It is therefore an obvious challenge to identify and to determine the role of survival proteins in cancer progression as well as in resistance to cancer therapies. In this study the eect of the transcription factor NF-kB on the sensitivity of Ewing tumor cells to apoptosis was investigated. The relevance of this question is based on the fact that NF-kB is associated with several malignancies (Baldwin, 1996) and is activated by chemotherapy and by irradiation of several tumor cell lines (Brach et al., 1991; Das and White, 1997) . Moreover, tumor in®ltrating leucocytes produce cytokines such as TNFa and IL1-b, which are strong inducers of NF-kB activity and thus may further in¯uence the sensitivity to cancer therapies.
The fact that EW7 cells contained very low levels of NF-kB activity and survived when they expressed the super repressor IkBa(A32/36) indicates that NF-kB activity is not necessary to the survival of these cells, at least in vitro.
The use of a super repressor form of IkBa allowed us to demonstrate that inhibition of the activation of NF-kB in response to TNFa potently enhanced the ability of this cytokine to initiate apoptosis in two Ewing tumor cell lines that are normally resistant to its killing eect. TNFa-pretreatment of EW7 cells, which have a very low basal NF-kB activity, decreased their susceptibility to doxorubicin-and daunorubicin-induced killing. In contrast, in IkBa(A32/36)-expressing EW7 cells, the percentage of apoptotic cells observed after treatment with doxorubicin or daunorubicin was higher in the TNFa-pretreated cells than in the nonpretreated ones. This observation con®rms our hypothesis that in¯ammatory cytokines, through their ability to induce NF-kB, may interfere with chemotherapeutic treatment.
The mechanism by which NF-kB exerts its antiapoptotic activity is not fully elucidated. Analysis of the expression of a panel of proteins with potential antiapoptotic activity allowed us to identify the cyclindependent kinase inhibitor p21
Waf1/Cip1 as a protein whose induction is triggered by TNFa. Our results corroborate those obtained by Jiang and Porter (1998) in MCF7 breast tumor cells. The fact that p21 Waf1/Cip1 induction did not occur in cells expressing the super repressor form of IkBa indicates that this induction is dependent on NF-kB activation. Whether the mechanism of this induction is direct or indirect, transcriptional or post-transcriptional is under investigation. In the IkBa(A32/36)-expressing cells, in which NF-kB and consequently p21
Waf1/Cip1 are no longer inducible by TNFa, overexpression of p21 Waf1/Cip1 decreased the susceptibility of these cells to TNFa-induced apoptosis. This result is in agreement with the previously described protective eect of p21 Waf1/Cip1 against cytotoxic stimulation in several other cell types. Indeed, it appears that in a variety of p53-independent or p53-dependent models of stress, the failure to elevate p21
Waf1/Cip1 expression is associated with low survival whereas induction of p21 Waf1/Cip1 causes increased survival. For example, induction of p21 Waf1/ Cip1 expression in H1299 lung cancer cells protected them against cytotoxic eects of radiation and doxorubicin (Wang et al., 1999b) . Similarly, ectopic expression of p21 Waf1/Cip1 in RKO colorectal carcinoma cells was found to confer protection against cyclopentone prostaglandin A2-mediated cell death (Gorospe et al., 1996) . In contrast, mice de®cient in p21
Waf1/Cip1 were more sensitive to radiation than normal mice (Brugarolas et al., 1995; Wang et al., 1997) . Also, in colorectal and melanoma cancer cells, inactivation of p21 Waf1/Cip1 rendered them sensitive to p53-induced apoptosis (Polyak et al., 1996; Gorospe et al., 1997) and prevention of TNFa-mediated induction of p21 Waf1/ Cip1 was shown to sensitize MCF7 cells to TNFainduced apoptosis (Jiang and Porter, 1998) .
The mechanism underlying the antiapoptotic eect of TNFa-induced p21
Waf1/Cip1 remains to be established. Several steps that are implicated in the apoptotic process have been shown to be inhibited by p21 Waf1/Cip1 . These include c-Jun N-terminal kinase (JNK) and caspase 3 activation (Shim et al., 1996; Suzuki et al., 1998) . Recently, it was described that during differentiation of vitamin D 3 -treated monocytes, inhibition of JNK activation occurred subsequently to relocalization of nuclear p21
Waf1/Cip1 to the cytoplasm where it binds to the apoptosis signal-regulating kinase 1 (ASK1) (Asada et al., 1999) . Alternatively, in human colorectal carcinoma cells, CDK-binding or CDKinhibitory activity of p21 Waf1/Cip1 was required to prevent apoptosis (Lu et al., 1998) . It will be interesting to determine whether the antiapoptotic eect of TNFa-induced p21
Waf1/Cip1 correlates with the cytoplasmic expression of this protein.
Our study allowed us to identify p21 Waf1/Cip1 as a novel mediator of the antiapoptotic eect of NF-kB. Several other proteins have been shown to be associated with the survival promoting eect of this transcription factor. Although we did not observe any modulation by TNFa of Bcl-2, c-IAP1 or c-IAP2 in EW7 cells, other NF-kB-regulated antiapoptotic proteins, including TRAF1 and TRAF2, Mn-SOD, A20, IEX-1L or B¯-1/A1 could also be implicated (Wang et al., 1998; Zong et al., 1999; reviewed in JaÈ aÈ ttelaÈ , 1999) . It is likely that the combined eect of these proteins, of which expression may vary from one cell type to another, explains the survival-enhancing acitivity of NF-kB. A protective eect of the fusion protein EWS ± FLI-1 against apoptosis of NIH3T3 cells induced by either serum deprivation or by treatment with calcium ionophore was also described (Yi et al., 1997) . However, it is unlikely that this protein participate in the NF-kB-induced resistance of Ewing tumor cells to TNFa since its expression was not modulated by this cytokine.
Our present ®nding supports the notion that inclusion of NF-kB inhibitors during conventional therapies may be bene®cial to the treatment of Ewing sarcoma. Such safe and speci®c inhibitors should be soon available since intense eorts in the pharmaceutical industries are presently pursued. Moreover, recent in vivo studies indicate that TNFa in parallel with NFkB inhibitors leads to direct tumor cell killing (Wang et al., 1999a) . Therefore, TNFa in combination with NFkB inhibitors could represent an ecient alternative treatment of Ewing tumors that have developped resistance to radiations or chemotherapies. Our observation that in situation of stress, enhanced expression or function by speci®cally designed compounds may also be bene®cial during tumor treatment.
Materials and methods
Expression vectors and reagents
The reporter plasmid (Igk)3-conaluc and its control counterpart conaluc were gifts from A Israel (Institut Pasteur, Paris). The MAD-3 double point mutant (position 32 and 36) (IkBaA32/36) construct was described by Traeckner et al. (1995) and was obtained from M. Korner (HoÃ pital PitieÂ SalpeÃ trieÁ re, Paris). The pCEP4 vector encoding p21
Waf1/Cip1 was a gift from B Vogelstein (Johns Hopkins University, Baltimore, USA). The pEGFP vector encoding the Green Fluorescence Protein (GFP) and the pCMV-b-galactosidase reporter vector were from Clontech.
Recombinant human TNFa (speci®c activity: 5610 7 U/ mg) was purchased from Bender Wien, doxorubicin and daunorubicin were from Sigma. DiOC6(3) and DEVD-pNA were from Calbiochem and Bioprobe, respectively.
Cells
The two Ewing's sarcoma cell lines, EW7 and EW1, established from a scapula tumor and a rib tumor, respectively, were provided by Pr G Lenoir (UniversiteÂ Lyon 1). EW7 cells had a wild-type p53 gene, whereas EW1 cells exhibited an arginine to cysteine mutation at codon 273 in the p53 gene (Richard Hamelin, personal communication). These cells express the EWS-FLI-1 chimeric protein.
EW7 or EW1 cells stably transfected with the empty pcDNA vector or with the IkBa(A32/36) encoding vector were obtained by electroporation (960 mF, 210 V) of 2610 7 cells with 10 mg of plasmid. Stable transfectants were selected and maintained in the presence of geneticin (1 mg/ml).
All cells were propagated in RPMI medium supplemented with 2 mM L-glutamine and 10% fetal calf serum in collagencoated culture¯asks.
Electrophoretic mobility shift assay (EMSA)
Nuclear extracts and EMSA were performed as previously described (BesancË on et al., 1998) . Brie¯y, the double-stranded consensus NF-kB probe: 5'-AGT TGA GGG GAC TTT CCC AGG C-3'; -3'-TCA ACT CCC CTG AAA GGG TCC G-5' was end-labeled using [g 32 P]ATP and T4 polynucleotide kinase. Binding reactions were carried out in a 20 ml binding reaction mixture (10 mM Tris-HCl, pH 7.5, 50 mM NaCl, 0.5 mM DTT, 10% glycerol, 0.2% Nonidet P-40, and 4 mg of poly(dI-dC)(dI-dC)) containing 10 mg of nuclear proteins and 0.5 ng of the radiolabeled probe. Samples were incubated for 45 min on ice and fractionated by electrophoresis on a 6% non-denaturing polyacrylamide gel in TAE buer (7 mM Tris, pH 7.5, 3 mM sodium acetate, 1 mM EDTA). Gels were run at 200 V for 3.5 h, dried and autoradiographed.
Reporter gene assays
Cells (1610 7 ) were washed twice with serum-free medium and incubated for 10 min at 48C with 10 mg of (Igk)3-conaluc-luciferase reporter and 0.5 mg of pCMV-b-gal in OptiMEM medium (GIBCO). Cells were then electroporated at 960 mF, 210 V, and plated in the appropriate medium for 16 h prior to harvest. Reporter gene activity was determined with the luciferase assay system (Promega). Transfection eciencies were normalized on the basis of b-galactosidase expression. b-galactosidase activity was measured using the luminiscent Galacto-Star assay system (Tropix).
Apoptosis assays
Fragmented nuclei were detected using staining with Hoechst 33258¯uorescent dye.
Variation of the mitochondrial membrane potential during apoptosis was studied using 3,3'-dihexyloxacarbocyanine iodide, DiOC 6 (3) (Calbiochem). 1610 6 cells were incubated in PBS containing 0.1 mM of DiOC 6 (3) for 30 min at 378C. Cells were then washed with PBS and subjected to FACS analysis.
Caspase 3 activity measurement was done using the CPP32 colorimetric substrate, DEVD-pNA (Bioprobe). Cells were suspended in lysis buer (0.5% Nonidet P-40, 0.5 mM EDTA, 150 mM NaCl, 50 mM Tris, pH 7.5) and kept on ice for 30 min, then centrifuged and supernatants were collected. Thirty micrograms of protein was incubated in a buer (10 mM HEPES, 0.1 M NaCl, 5 mM DTT) supplemented with DEVD-pNA substrate (200 mM) at 378C for 2 h. The released p-nitroaniline was monitored with a plate reader at 405-nm wavelength.
Western blot analysis
Cellular extracts were prepared in 10 mM Tris pH 7.4, 1% SDS, 1 mM sodium vanadate, treated with Benzon nuclease for 5 min at room temperature and boiled for 3 min. Fifty micrograms of proteins were loaded on a SDS-polyacrylamide gel. After electrophoresis, proteins were electrotransferred onto a nitrocellulose membrane. Membranes were blocked with 5% non-fat milk, 0.1% Tween-20 and then probed with monoclonal anti-p21
Waf1/Cip1 (Transduction Laboratories), anti-Bcl-2 (Santa Cruz), anti-actin (ICN), antip53 (Pharmigen) or anti-c-IAP1 (Pharmigen) antibodies or polyclonal anti-IkBa or anti-c-IAP2 antibodies (Santa Cruz). The 7.3 monoclonal anti-EWS ± FLI-1 antibody has been described previously (Melot et al., 1997) . The primary antibodies were labeled with horseradish peroxydase-conjugated anti-mouse or anti-rabbit secondary antibodies and detected by a chemiluminescence detection system (ECL, Amersham). The experiments were repeated three times and representative autoradiograms are shown.
